POLYMED.BO
POLYMED.BO
INE205C01021
POLY MEDICURE LTD.
Loading chart...

Company Profile

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

Related stocks

AGARWALEYE.NS
AGARWALEYE.NS • India
DR AGARWALS HEALTH CARE L
477.75 INR
1.56B USD 1Y -5.1%
3360.T
3360.T • Japan
SHIP HEALTH CARE HOLDINGS INC
2,458.5 JPY
1.4B USD 1Y +5.9%
8086.T
8086.T • Japan
NIPRO CORP
1,319 JPY
1.36B USD 1Y -12.3%
7716.T
7716.T • Japan
NAKANISHI INC
1,433 JPY
1.48B USD 1Y +32.7%
1501.HK
1501.HK • China
INT MEDICAL
32.36 HKD
1.16B USD 1Y +4.6%
300573.SZ
300573.SZ • China
XQYY
35.55 CNY
1.89B USD 1Y -23.3%
300888.SZ
300888.SZ • China
WINNERMEDICAL
31.36 CNY
2.74B USD 1Y -19.2%
300171.SZ
300171.SZ • China
TOFFLON
15.96 CNY
1.83B USD 1Y +9.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.1% p.a.
Max Drawdown (5Y)
-62.4%
Sharpe Ratio (5Y)
0.22
Beta Factor
0.00
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 51.0 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -62.4% in the extended horizon.
ende